View Future GrowthMagis 過去の業績過去 基準チェック /26Magisは、平均年間6.1%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 減少しています。収益は、平均年間4.4% 1.8%収益成長率で 成長しています。 Magisの自己資本利益率は7%であり、純利益率は4.1%です。主要情報6.15%収益成長率-15.72%EPS成長率Chemicals 業界の成長12.41%収益成長率1.81%株主資本利益率6.96%ネット・マージン4.08%前回の決算情報31 Dec 2025最近の業績更新Reported Earnings • Sep 29First half 2024 earnings releasedFirst half 2024 results: Revenue: €43.8m (up 4.7% from 1H 2023). Net income: €4.52m (up 1.4% from 1H 2023). Profit margin: 10% (in line with 1H 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany.Reported Earnings • Sep 25First half 2023 earnings releasedFirst half 2023 results: Net income: €4.46m (up €4.46m from 1H 2022).すべての更新を表示Recent updatesBoard Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 2 highly experienced directors. 1 independent director (6 non-independent directors). Independent Director Debora Mazzaccherini was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Apr 14Magis S.p.A., Annual General Meeting, Apr 28, 2026Magis S.p.A., Annual General Meeting, Apr 28, 2026, at 09:30 W. Europe Standard Time.お知らせ • Oct 24Magis S.p.A. (BIT:MGS) announces an Equity Buyback for €0.8 million worth of its shares.Magis S.p.A. (BIT:MGS) announces an share repurchase program. Under the program, the company will repurchases up to €0.8 million. The program will valid till 18 months.お知らせ • Apr 15Magis S.p.A., Annual General Meeting, Apr 28, 2025Magis S.p.A., Annual General Meeting, Apr 28, 2025, at 16:30 W. Europe Standard Time.お知らせ • Apr 02Magis S.p.A. announces Annual dividend, payable on May 07, 2025Magis S.p.A. announced Annual dividend of EUR 0.9200 per share payable on May 07, 2025, ex-date on May 05, 2025 and record date on May 06, 2025.Reported Earnings • Sep 29First half 2024 earnings releasedFirst half 2024 results: Revenue: €43.8m (up 4.7% from 1H 2023). Net income: €4.52m (up 1.4% from 1H 2023). Profit margin: 10% (in line with 1H 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany.New Risk • Sep 27New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 8.9% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Shareholders have been diluted in the past year (8.9% increase in shares outstanding). Market cap is less than US$100m (€63.5m market cap, or US$70.9m).New Risk • Apr 14New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€51.5m market cap, or US$54.8m).Reported Earnings • Sep 25First half 2023 earnings releasedFirst half 2023 results: Net income: €4.46m (up €4.46m from 1H 2022).Board Change • Jan 26Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Independent Director Debora Cascina was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.収支内訳Magis の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史DB:ZF6 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Dec 2577312030 Sep 2578412030 Jun 2579612031 Mar 2580712031 Dec 2481912030 Sep 2482811030 Jun 2482811031 Mar 2481811031 Dec 2380810030 Sep 2382810030 Jun 2383710031 Mar 2388710031 Dec 2293811030 Sep 2290810030 Jun 2287710031 Mar 2279610031 Dec 2170410031 Dec 2053190質の高い収益: ZF6は 高品質の収益 を持っています。利益率の向上: ZF6の現在の純利益率 (4.1%)は、昨年(10.7%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: ZF6の収益は過去 5 年間で年間6.1%増加しました。成長の加速: ZF6は過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: ZF6は過去 1 年間で収益成長率がマイナス ( -63.7% ) となったため、 Chemicals業界平均 ( -13.5% ) と比較することが困難です。株主資本利益率高いROE: ZF6の 自己資本利益率 ( 7% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/09 09:28終値2026/06/09 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Magis S.p.A. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Andrea BonfaBanca Akros S.p.A. (ESN)Marco GrecoValueTrack
Reported Earnings • Sep 29First half 2024 earnings releasedFirst half 2024 results: Revenue: €43.8m (up 4.7% from 1H 2023). Net income: €4.52m (up 1.4% from 1H 2023). Profit margin: 10% (in line with 1H 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Sep 25First half 2023 earnings releasedFirst half 2023 results: Net income: €4.46m (up €4.46m from 1H 2022).
Board Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 2 highly experienced directors. 1 independent director (6 non-independent directors). Independent Director Debora Mazzaccherini was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Apr 14Magis S.p.A., Annual General Meeting, Apr 28, 2026Magis S.p.A., Annual General Meeting, Apr 28, 2026, at 09:30 W. Europe Standard Time.
お知らせ • Oct 24Magis S.p.A. (BIT:MGS) announces an Equity Buyback for €0.8 million worth of its shares.Magis S.p.A. (BIT:MGS) announces an share repurchase program. Under the program, the company will repurchases up to €0.8 million. The program will valid till 18 months.
お知らせ • Apr 15Magis S.p.A., Annual General Meeting, Apr 28, 2025Magis S.p.A., Annual General Meeting, Apr 28, 2025, at 16:30 W. Europe Standard Time.
お知らせ • Apr 02Magis S.p.A. announces Annual dividend, payable on May 07, 2025Magis S.p.A. announced Annual dividend of EUR 0.9200 per share payable on May 07, 2025, ex-date on May 05, 2025 and record date on May 06, 2025.
Reported Earnings • Sep 29First half 2024 earnings releasedFirst half 2024 results: Revenue: €43.8m (up 4.7% from 1H 2023). Net income: €4.52m (up 1.4% from 1H 2023). Profit margin: 10% (in line with 1H 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany.
New Risk • Sep 27New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 8.9% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Shareholders have been diluted in the past year (8.9% increase in shares outstanding). Market cap is less than US$100m (€63.5m market cap, or US$70.9m).
New Risk • Apr 14New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€51.5m market cap, or US$54.8m).
Reported Earnings • Sep 25First half 2023 earnings releasedFirst half 2023 results: Net income: €4.46m (up €4.46m from 1H 2022).
Board Change • Jan 26Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Independent Director Debora Cascina was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.